Caglitide is an artificial peptide developed to treat type 2 diabetes and obesity. It reduces blood calcium and weight loss by activating amylin and calcitonin receptors. In clinical trials, caglitide has been shown to be more effective in reducing weight and blood sugar than monotherapy (refer to relevant literature)
